The correlation between serum E-selectin levels and soluble interleukin-2 receptors with relation to disease activity in localized scleroderma

被引:6
作者
Wodok-Wieczorek, Karolina [1 ]
Salwowska, Natalia [2 ]
Sygula, Ewa [1 ]
Wodok, Aleksandra [3 ]
Wcislo-Dziadecka, Dominika [4 ]
Bebenek, Katarzyna [3 ]
Bergler-Czop, Beata [2 ]
Brzezinska-Wcisto, Ligia [2 ]
机构
[1] Andrzej Mielecki Independent Publ Clin Hosp, Dept Dermatol, Katowice, Poland
[2] Med Univ Silesia, Sch Med Katowice, Dept Dermatol, Katowice, Poland
[3] Med Univ Silesia, Sch Med Katowice, Katowice, Poland
[4] Med Univ Silesia, Div Lab Med Sosnowiec, Sch Pharm, Dept Cosmetol, 3 Kasztanowa St, PL-41200 Katowice, Poland
来源
POSTEPY DERMATOLOGII I ALERGOLOGII | 2018年 / 35卷 / 06期
关键词
E-selectin; interleukin-2; receptors; localized scleroderma; connective tissue disease; INDEX;
D O I
10.5114/ada.2018.77613
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Introduction: Scleroderma is a chronic connective tissue disease resulting in fibrosis. Aim: The aim of the study was to determine the connection between sE-selectin and sIL-2R and the severity of skin lesions in various subtypes of LoS. Evaluation of disease severity, the location of skin lesions, the duration of symptoms and disease activity were assessed in relation to the three different LoS subtypes in patients with localized scleroderma. Material and methods: The study included 42 patients with localized scleroderma and the control group consisted of 41 healthy subjects. All patients in the LoS study group had a confirmed diagnosis via skin biopsy and underwent serology testing for sE-selectin and sIL-2R concentrations by enzyme-linked immunosorbent assay (ELISA). Results: Significantly higher levels of sE-selectin and sIL-2R were observed in the LoS study group when compared with the control group (p < 0.001). The analysis showed a result close to statistical significance (p = 0.058) between sE-selectin concentration during the time of active disease in the LoS study group. The highest concentrations of sE-selectin and sIL-2R were observed in patients with the generalized subtype of LoS. A positive, statistically significant, curvilinear relationship was shown amid the modified Localized Skin Severity Index (mLoSSI) and sE-selectin and sIL-2R concentrations in the LoS study group. Conclusions: Concentrations of the circulating form of sE-selectin appear to be an adequate marker of the endothelial function, positively correlating with the severity of the disease. The proven correlation of sIL-2R concentrations with the severity of the disease indicates that it is a valuable prognostic factor for predicting the impending course of the disease.
引用
收藏
页码:614 / 619
页数:6
相关论文
共 23 条
  • [1] Arkachaisri T, 2008, J RHEUMATOL, V35, P650
  • [2] Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease Damage: a proof-of-concept study
    Arkachaisri, Thaschawee
    Vilaiyuk, Soamarat
    Torok, Kathryn S.
    Medsger, Thomas A., Jr.
    [J]. RHEUMATOLOGY, 2010, 49 (02) : 373 - 381
  • [3] The Localized Scleroderma Skin Severity Index and Physician Global Assessment of Disease Activity: A Work in Progress Toward Development of Localized Scleroderma Outcome Measures
    Arkachaisri, Thaschawee
    Vilaiyuk, Soamarat
    Li, Suzanne
    O'Neil, Kathleen M.
    Pope, Elena
    Higgins, Gloria C.
    Punaro, Marilynn
    Rabinovich, Egla C.
    Rosenkranz, Margalit
    Kietz, Daniel A.
    Rosen, Paul
    Spalding, Steven J.
    Hennon, Teresa R.
    Torok, Kathryn S.
    Cassidy, Elaine
    Medsger, Thomas A., Jr.
    [J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (12) : 2819 - 2829
  • [4] Vascular biomarkers and correlation with peripheral vasculopathy in systemic sclerosis
    Chora, Ines
    Guiducci, Serena
    Manetti, Mirko
    Romano, Eloisa
    Mazzotta, Celestina
    Bellando-Randone, Silvia
    Ibba-Manneschi, Lidia
    Matucci-Cerinic, Marco
    Soares, Raquel
    [J]. AUTOIMMUNITY REVIEWS, 2015, 14 (04) : 314 - 322
  • [5] Systemic and locatized scleroderma
    Chung, Lorinda
    Lin, Jan
    Furst, Daniet E.
    Fiorentino, David
    [J]. CLINICS IN DERMATOLOGY, 2006, 24 (05) : 374 - 392
  • [6] Clinical advances in therapies targeting the interleukin-2 receptor
    Church, AC
    [J]. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2003, 96 (02) : 91 - 102
  • [7] L-selectin and Skin Damage in Systemic Sclerosis
    Dunne, James V.
    van Eeden, Stephan F.
    Keen, Kevin J.
    [J]. PLOS ONE, 2012, 7 (09):
  • [8] Dziankowska-Bartkowiak B, 2007, POSTEP DERM ALERGOL, V24, P256
  • [9] Update on morphea Part I. Epidemiology, clinical presentation, and pathogenesis
    Fett, Nicole
    Werth, Victoria P.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : 217 - 228
  • [10] Serum Adhesion Molecule Levels as Prognostic Markers in Patients with Early Systemic Sclerosis: A Multicentre, Prospective, Observational Study
    Hasegawa, Minoru
    Asano, Yoshihide
    Endo, Hirahito
    Fujimoto, Manabu
    Goto, Daisuke
    Ihn, Hironobu
    Inoue, Katsumi
    Ishikawa, Osamu
    Kawaguchi, Yasushi
    Kuwana, Masataka
    Ogawa, Fumihide
    Takahashi, Hiroki
    Tanaka, Sumiaki
    Sato, Shinichi
    Takehara, Kazuhiko
    [J]. PLOS ONE, 2014, 9 (02):